PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2016.34.1.120163411-9Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatmentTaeryool Koo, In Ah Kimhttp://www.e-roj.org/upload/pdf/roj-34-1.pdf, http://www.e-roj.org/journal/view.php?doi=10.3857/roj.2016.34.1.1, http://www.e-roj.org/upload/pdf/roj-34-1.pdf
Breast Care10.1159/0005123282020156570-578Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Current Treatment Standards and Future PerspectivesClemens Dormannhttps://www.karger.com/Article/Pdf/512328, https://www.karger.com/Article/Pdf/512328
Breast Cancer10.1007/s12282-013-0446-62013202103-110Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancerRicardo H. Alvarez, Gabriel N. Hortobagyihttp://link.springer.com/content/pdf/10.1007/s12282-013-0446-6.pdf, http://link.springer.com/article/10.1007/s12282-013-0446-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12282-013-0446-6
Hong Kong Journal of Radiology10.12809/hkjr1916852201922286-97Expanding Treatment Arsenal for Oestrogen Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast CancerHenry Szehttp://www.hkjr.org/article/v22n2/expanding
Cancer Management and Research10.2147/cmar.s982492016Volume 885-94Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerWilliam Gradisharhttps://www.dovepress.com/getfile.php?fileID=31308
OncoTargets and Therapy10.2147/ott.s770332016Volume 96119-6125Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancerKatalin Boérhttps://www.dovepress.com/getfile.php?fileID=32885, https://www.dovepress.com/getfile.php?fileID=32885
Cancer Management and Research10.2147/cmar.s1172742016Volume 8127-128Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerHikmat Abdel-Razeqhttps://www.dovepress.com/getfile.php?fileID=33071, https://www.dovepress.com/getfile.php?fileID=33071
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(07)80363-82007183308-309Prognostic Significance of Human Epidermal Growth Factor Receptor Positivity for the Development of Brain Metastasis After Newly Diagnosed Breast CancerM.E. Meliskohttps://api.elsevier.com/content/article/PII:S1043321X07803638?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X07803638?httpAccept=text/plain
Breast Cancer Research and Treatment10.1007/s10549-021-06383-520211902189-201Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancerJason A. Mouabbi, C. Kent Osborne, Rachel Schiff, Mothaffar F. Rimawihttps://link.springer.com/content/pdf/10.1007/s10549-021-06383-5.pdf, https://link.springer.com/article/10.1007/s10549-021-06383-5/fulltext.html, https://link.springer.com/content/pdf/10.1007/s10549-021-06383-5.pdf
Cancer Medicine10.1002/cam4.20952019851943-1957Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A reviewJunjie Li, Zhonghua Wang, Zhimin Shaohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcam4.2095, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2095, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.2095, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2095